This website uses cookies to enhance the user experience.
E

EURONLABS AS933 101 703

Research
Limited company
Ensjøveien 18 0661 OSLO, Norge

EURONLABS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
1 year
since Apr 10, 2024
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Annual total result 2024
-649
NOK
Total equity 2024
29,351
NOK
Last update: Aug 4, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
22.58 %
indirectly

Board

NameRoleShares
Chairman-
Board Member
22.58 %
indirectly
NH
Board Member-

Others

NameRoleShares
M
MR ØKONOMI AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Board Member
22.58 %
indirectly
-
15.48 %
indirectly
-
15.48 %
indirectly
-
12.34 %
indirectly
-
10 %
indirectly
-
7.48 %
indirectly
-
3.74 %
indirectly
-
3.74 %
indirectly
-
3.74 %
indirectly
-
3.34 %
indirectly
Last update: May 30, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
E
EURON VENTURE GROUP AS
Ordinary shares
30,000
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2023: NOK 305,931
    Operating profit 2023: NOK -1,521,404
    Employees: 0

Financials

in NOK

Summary

Year2024
Total operating income
0
Annual Total Result
-649
Total assets
29,351
Total liabilities
0
Total equity
29,351

P&L

Year2024
Total operating income
0
Total operating costs
841
Operating result
-841
Financial income/costs
8
Profit before tax
-832
Total tax & extraordinary income/cost
-183
Annual Total Result
-649

Balance overview

Year2024
Total fixed assets
183
Total current assets
29,168
Total assets
29,351
Short term debt
0
Long term debt
0
Total liabilities
0
Contributed capital
30,000
Retained earnings
-649
Total equity
29,351
Total equity and liabilities
29,351

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology